echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Researchers have developed an all-in-one detection method to prevent embryos from developing new genetic diseases

    Researchers have developed an all-in-one detection method to prevent embryos from developing new genetic diseases

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The newborn variant (dnv) is a genetic mutation that was previously unrecognizable in the family history of one of the two potential parents and could cause illness in any children they give birth
    .


    In the case of a parent with disease-causing DNV, the risk of passing it to their children can be as high as 50%, and the ability to identify healthy embryos for transfer to avoid affected pregnancy is obviously a priority


    Dr.
    Eftychia Dimitriadou, the head of the Reproductive Genetics Department of the Human Genetics Center at Leuven University Hospital in Belgium, and his colleagues recruited 22 couples, one of whom carried the DNV mutation that causes Mendelian disease
    .


    Mendelian disease is usually (but not always) caused by changes in a single gene


    The researchers decided to try to simplify this process using Long Read Sequencing (LRS), a technique that can read the sequence of very long DNA fragments
    .


    The main advantage of LRS is that it more accurately detects copy number mutations, deleted or replicated DNA fragments, and single nucleotide variations (SNVs), for example, changing the sequence of a single DNA molecule, especially in regions that are the same DNA fragments are repeated


    Dr.
    Dimitriadou said: "This allows us to determine whether the mutation that causes the disease is located in the maternal or paternal line of the affected chromosome of dnv patients
    .


    " Embryos-all of this is carried out in a single workflow


    In addition to detecting dominant genetic diseases (one copy of a disease-related mutation is enough to cause the disease), the test can also detect embryos with an abnormal number of chromosomes throughout the genome (aneuploidy)
    .


    However, a comprehensive test does not mean that every single genetic abnormality can be detected


    This new test has only recently begun clinical application, but in the 23 in vitro fertilization/PGT cycles that have been performed, 15 embryos have no mutations, no detectable genome-wide genetic abnormalities, and are of sufficient quality for transplantation
    .


    Six people became pregnant and three babies were born


    "Because children born with genetic diseases often have serious physical manifestations, it is understandable that parents often worry about the risk of their children suffering from genetic diseases, such as neurofibromatosis 1 or Alport syndrome 2.

    For parents Said that the discovery of one of them with this disease has already brought them a huge emotional burden, so we are proud to bring new hope to the affected families.



    "However, there is a dark cloud on the horizon
    .


    The EU In Vitro Device Regulation (IVDR), which will take effect in May 2022, may ban our hospitals from "independently developed" new innovative tests


    Professor Alexander Raymond, chair of the ESHG conference and director of the Center for Integrated Genomics at the University of Lausanne, Switzerland, said: "The original goal of reproductive medicine was to allow infertile couples to have children
    .
    In the 43 years since the birth of the first IVF, rapid progress has been made.
    It has brought many advancements, including prenatal diagnosis
    .
    Now, through long-read sequencing, it has taken another step forward, helping families with “gene at risk” hope to have unaffected offspring
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.